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Abstract
Background & Aims—Features of eosinophilic esophagitis (EoE) and gastroesophageal reflux
disease (GERD) overlap; because they cannot be differentiated based on eosinophil counts alone, it
can be a challenge to distinguish between these disorders. We aimed to characterize the clinical,
endoscopic, and histologic features of EoE and GERD and identify factors that might be used to
differentiate them.
Methods—We performed a retrospective case-control study on data collected from 2000 to 2007.
Cases were patients of any age with EoE, as defined by recent consensus guidelines; controls were
patients of any age with GERD. Clinical and endoscopic data were collected and all esophageal
biopsy specimens were reassessed by gastrointestinal pathologists. Cases and controls were
compared, unconditional logistic regression was performed to develop a model to predict EoE, and
receiver operator characteristic curves were constructed.
Results—Data from 151 patients with EoE and 226 with GERD were analyzed. Compared to
GERD, features that independently predicted EoE included younger age; symptoms of dysphagia;
documented food allergies; observations of esophageal rings, linear furrows, white plaques, or
exudates by upper endoscopy; an absence of a hiatal hernia, observed by upper endoscopy; a higher
maximum eosinophil count; and the presence of eosinophil degranulation, observed in biopsy
specimens. The area under the curve for this model was 0.934.
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Conclusions—We identified a set of readily available and routinely measured variables that
differentiate EoE from GERD. Use of this type of analysis with patients suspected to have EoE might
lead to more accurate diagnoses.
Introduction
Eosinophilic esophagitis (EoE) is an emerging condition characterized by a constellation of
clinical, endoscopic, and histopathologic features.1 In the context of the correct symptoms,
such as dysphagia, food impaction, heartburn, and in children, failure to thrive,2–6 and
endoscopic findings, such as rings, linear furrows, or white plaques,5, 7–9 a demonstration of
prominent esophageal eosinophilia on biopsy can suggest the diagnosis.10, 11 Recently
published consensus guidelines have proposed formal diagnostic criteria,1 but because many
of the clinical findings related to EoE may be non-specific, in practice it can be challenging to
confirm the diagnosis of EoE.
The most common disorder which must be distinguished from EoE is gastroesophageal reflux
disease (GERD).1, 12, 13 This differentiation is critical, as evaluation, treatment, and prognosis
for the two conditions are widely divergent. The symptoms of both conditions overlap
substantially,14, 15 potentially related pathogenic mechanisms have been proposed,12 and
elevated eosinophil counts, the presumed hallmark of EoE, are not specific.14–16 Moreover,
much of the literature on EoE is based on analyses of series of, or comparisons between groups
of, EoE patients. Only limited published data exist comparing EoE patients to those without
EoE,17–20 and comparing EoE to GERD.21–24
The aims of this study were to thoroughly characterize clinical, endoscopic, and histologic
features in a large number of patients with EoE of any age, compare them to GERD patients,
and determine factors that could reliably differentiate the two conditions. We hypothesized
that a combination of specific symptoms, esophageal mucosal abnormalities, and pathologic
findings beyond simple eosinophil counts would predict a diagnosis of EoE.
Methods
Study design and patients
We conducted a retrospective case-control study at the University of North Carolina (UNC)
Hospitals. All patients were selected from the UNC EoE clinicopathologic database, which
contains information on patients with esophageal eosinophilia from any cause from January
2000 through December 2007. This resource was originally constructed by searching the UNC
pathology database for every esophageal biopsy obtained over this time frame and then
narrowing the search to those reports with any mention of the term “eosinophil”.
Cases were patients of any age with EoE, as defined by the recent consensus guidelines.1
Specifically, patients needed to have ≥ 15 eosinophils in at least one high-powered field (eos/
hpf) and at least one typical symptom of esophageal dysfunction (i.e. dysphagia, food
impaction, heartburn, or feeding intolerance), with other causes of esophageal eosinophilia
excluded, and without a response to acid-suppression. When available (n = 79), response to
acid-suppression was assessed by esophageal biopsy; otherwise, response was assessed by
symptoms. Because these diagnostic guidelines were published at the end of this study period,
they were applied in a retrospective fashion to every potential case identified, and the data
sources specified below were utilized to confirm case status. In addition, only incident cases
were included, and these were categorized by esophageal biopsy date.
Controls were patients of any age with GERD who also underwent
esophagogastroduodenoscopy (EGD)and biopsy over this time course. GERD patients were
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defined by at least one typical symptom (i.e. heartburn, regurgitation, pain, failure to thrive)
which was the main indication for EGD, consistent biopsy findings (inflammation), and a
clinical evaluation which excluded other possible causes. They could have either erosive or
non-erosive disease. There were no restrictions on esophageal eosinophil counts in the GERD
patients, and controls were also categorized by their esophageal biopsy date. Patients with
confirmed Barrett’s esophagus were not included in the study population, nor were patients
newly diagnosed with Barrett’s as a consequence of the upper endoscopy included in this study.
Cases and controls were not matched.
Data sources and variables
Clinical data were abstracted from the UNC electronic medical record. Covariates of interest
included: demographic factors (date of birth, gender, race); symptoms (dysphagia, food
impaction, heartburn or regurgitation, chest pain, abdominal pain, nausea, vomiting, crying,
failure to thrive); coexisting atopic disease (allergic rhinitis or sinusitis, documented food
allergy (demonstrated by either symptomatic evidence of allergy with reintroduction of a food
or by testing directed by an Allergist), asthma); medication use at the time of endoscopy;
selected lab values as available (peripheral eosinophil count, IgE level, erythrocyte
sedimentation rate (ESR), C-reactive protein (CRP)); and results from ambulatory pH
monitoring and esophageal manometry.
Endoscopic data was extracted from our electronic database, ProvationMD (Provation
Medical, Minneapolis, MN), with attention to the EGD indication as well as endoscopist-
reported esophageal findings. These included: a normal esophagus (no findings), rings,
strictures, a narrow-caliber esophagus, linear furrows, delicate or easily torn mucosa (so-called
“crêpe-paper” mucosa), white plaques or exudates, erythema, erosions, decreased vascularity,
esophagitis, ulceration, hiatal hernia, as well as any other pertinent finding. We also determined
the overall case volume of EGDs for each of the study years, as well as the number and type
of cases during which esophageal biopsies were performed.
Histopathologic interpretation
Once appropriate cases and controls were identified, all original pathology slides were retrieved
from archival status and re-examined. Each slide was re-read by one of three study pathologists
(KJF, TCR, JTW) according to a protocol our group has previously validated which has
excellent inter- and intra-observer reliabiltiy.25, 26 In brief, each glass slide was blinded,
scanned and converted to a digital slide, and viewed with Aperio ImageScope (Aperio
Technologies, Vista, CA). The eosinophil density (eosinophils/um2) was then determined for
five areas: the area of maximum eosinophilia, the area that was judged to be the next-most
densely infiltrated with eosinophils, and three areas that were representative of the biopsy
specimen overall. For purposes of comparison to previously published studies, eosinophil
density was converted to eos/hpf for an assumed hpf size of 0.24 mm2, the size of an average
field as reported in the literature.6
In addition, for each of the five areas, the presence of degranulating eosinophils (defined as
eosinophilic granules in the proximity of a eosinophil, but not in isolation),10, 11 the presence
of eosinophilic microabscesses (defined as clusters of ≥ 4 eosinophils),10 the mucosal and
biopsy distribution of eosinophils, the presence of spongiosis, and the presence of laminal
propria fibrosis was noted. For analysis, if any of these findings were present in one area, then
that biopsy was analyzed as having that specific finding. Finally, because pathologists may use
a variety of indicators when assessing a biopsy specimen, each pathologist made a global (but
blinded) determination of whether their findings were consistent with EoE “in the correct
clinical context”.
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Statistical analysis was performed using Stata version 9 (Statacorp, College Station, TX).
Descriptive statistics were used to summarize characteristics of the study population. The
number of incident cases of EoE diagnosed each year of the study was determined, and this
number was standardized by the total number of EGDs performed each year, the number of
cases with esophageal biopsies, and the number of esophageal biopsies performed during
procedures evaluating dysphagia in order to determine whether observed trends were
potentially due to increased detection.
Bivariate analysis was used to compare the case and control groups. Chi-square was used for
categorical variables, and t-test or ANOVA were used for continuous variables. To examine
seasonal variation of diagnosis, the month of diagnosis was categorized to create typical
seasons: winter was December through February; spring was March through May; summer
was June through August; and fall was September through November. Proportions within
groups were compared with the chi-square goodness-of-fit test, and proportions between
groups were compared with chi-square.
Multivariate analysis with unconditional logistic regression was used to develop predictive
models. The main outcome was a diagnosis of EoE (yes/no). Results of the bivariate analysis,
as well as results of multivariate modelling within sets of clinical, endoscopic, and histologic
characteristics, informed the initial candidate variable selection for the model. Then, the model
was reduced with a backwards elimination strategy, a priori retaining variables that were
significant at a p < 0.10 level or were felt to be clinically important. Receiver operator
characteristic (ROC) curves were constructed, and the area under the curve (AUC) calculated.
Reliability and stability of the final predictive model were tested with the Hosmer-Lemeshow
goodness-of-fit test, an examination of classification statistics, and bootstrap stepwise
regression (to assess the frequency at which the chosen variables would be selected to remain
in the model). The analysis was then repeated with the study population stratified by adult (age
≥ 18 years) or child (age < 18) status. Because a component of eosinophil count was included
in the case definition but was a potential predictor variable, we also conducted a sensitivity
analysis with and without this variable in the final model, as well as an assessment of
incorporating the mean eosinophil count, which is not part of the case definition, in the model.
Patients with missing data were excluded from both the bivariate and multivariate analysis.
This study was approved by the UNC Institutional Review Board, and complied with published
criteria for conducting and reporting observational studies.27
Results
Study subjects
Of the 456 candidate patients identified in the database for this study, 151 were found to have
EoE meeting our case definition, and 226 had GERD meeting our control definition. Of the
EoE patients, 79 (52%) had persistent eosinophilia on esophageal biopsy while on acid
suppression (69 with a PPI and an additional 10 with an H2-receptor antagonist); the remainder
did not have a symptom response to acid suppression. There were 22 patients who had either
EoE or GERD, but the medical record contained insufficient data to make a definite
determination, and there were 37 patients whose EoE or GERD status could not be determined.
Of the remaining 20 patients, esophageal eosinophilia was explained in 4 by achalasia, and 1
each by graft-versus-host-disease, celiac disease, and a parasitic infection; the other 13 had no
esophageal disease.
Missing data accounted for ≤ 12% of all observations with exceptions as noted in Table 1. In
all cases, missing data were non-differentially distributed between the EoE and GERD groups.
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Increasing incidence of EoE
Over the eight year time frame of this study, the number of cases of EoE diagnosed at our
center increased dramatically in both pediatric and adult populations (Figure 1A). No cases
were found in 2000, while 60 were identified in 2007. While there were increases in EGD and
esophageal biopsy volume (65% and 77% increases respectively from 2002 to 2007), as well
as increases in biopsies performed in patients undergoing EGD for an indication of dysphagia
(104% increase from 2002 to 2007), the increase in the number of EoE cases diagnosed (750%
increase from 2002 to 2007) far outpaced this (Figure 1B). This suggests that increased
recognition alone was not the responsible for the observed trends in diagnosis.
Clinical characteristics: EoE vs GERD
There were multiple differences in clinical characteristics between the EoE and GERD groups
(Table 1). Cases of EoE were younger than GERD cases (25 vs 33 years; p = 0.001) and were
comprised of a higher proportion of males (77% vs 58%; p < 0.001). Symptoms were also
different, with cases of EoE having more dysphagia and food impaction, and GERD patients
noting more heartburn and abdominal pain. Interestingly, the proportion of patients reporting
heartburn was high in both groups (46% of EoE patients vs 56% of GERD patients; p = 0.009).
For EoE patients, the type of symptom varied by age (see Figure 2A). Non-specific symptoms
were seen in younger patients, while more “typical” symptoms of food impaction or dysphagia
were seen in comparatively older patients. Specifically, when comparing symptoms between
pediatric and adult populations, failure to thrive, vomiting, and heartburn were significantly
more common in children than in adults, and food impaction and dysphagia were significantly
more common in adults (see Figure 2B).
Atopic diseases, such as allergic rhinitis or dermatitis, documented food allergies, and asthma,
were also more common in the EoE group. In addition, the season of diagnosis varied between
the groups (p = 0.02). Cases of EoE were most commonly diagnosed during summer months
(p = 0.007), while there was no seasonal trend with GERD (p = 0.87).
Endoscopic characteristics: EoE vs GERD
The endoscopic findings also differed substantially between the EoE and GERD groups (Table
2). The most common EGD indication in the EoE group was dysphagia (58%), while heartburn
(32%) and abdominal pain (30%) were the most common in the GERD group.
Overall, the esophagus was reported to be normal in 21% of EoE patients and in 27% of GERD
patients (p = 0.16). Rings, strictures, a narrowed esophagus, linear furrows, crêpe-paper
mucosa, and white plaques were all more common in the EoE group, while hiatal hernias were
more common in the GERD group. Interestingly, the proportion of patients with esophagitis
was similar in the EoE and GERD groups (35% vs 42%; p = 0.21). For EoE patients, the EGD
findings varied by age (Figure 2C). A normal appearing esophagus and inflammatory-type
findings were seen in younger patients, while more “classic” findings were seen in
comparatively older patients (mean age range 31–37 years). Specifically, when comparing
endoscopic findings between pediatric and adult populations, a normal appearance, white
plaques, erythema, or erosive esophagitis were significantly more common in children than in
adults, and esophagela narrowing, strictures, crêpe-paper mucosa, and rings were significantly
more common in adults (see Figure 2C).
Histopathologic characteristics: EoE vs GERD
Histopathologic features distinguished the EoE and GERD groups as well (Table 3). The mean
of the maximum eosinophil counts in the EoE group was 121, compared with 34 in the GERD
group (p < 0.001), and the mean count in 5 hpfs in the EoE group was 76 compared with 16
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in the GERD group (p < 0.001). In general, there was no variation in eosinophil count by clinical
symptom in either group, or by endoscopic findings with the exception of white plaques. In
the EoE group, patients with white plaques had a maximum eosinophil count of 197 compared
with a count of 114 in patients without this finding (p = 0.005).
Eosinophil degranulation was more commonly present in the EoE group compared with the
GERD group (94% vs 52%; p < 0.001), as was the presence of eosinophil microabscesses (67%
vs 19%; p < 0.001). The distribution of eosinophils also varied between the groups. In the EoE
group, the mucosal distribution was almost always diffuse (92% compared with 77% in the
GERD group; p = 0.004), and the biopsy distribution was also diffuse (65% vs 21%; p < 0.001).
Spongiosis was more commonly seen in the EoE group (89% vs 59%; p < 0.001). When
subepithelial tissue was present in the biopsy samples, significant lamina propria fibrosis was
not seen in either group.
Predictive modelling
Nine key variables were retained in our final predictive model (Table 4). These were: age at
biopsy/diagnosis, dysphagia as a symptom; the presence of a documented food allergy; the
presence of rings on EGD; the presence of linear furrows on EGD, the presence of white plaques
or exudates seen on EGD; the presence of a hiatal hernia on EGD; the maximum eosinophil
count; and the presence of eosinophil degranulation on the biopsy specimen. All were
significant at the p = 0.05 level with the exception of age, linear furrows, and white plaques.
This model had excellent predictive ability when an ROC curve was constructed (Figure 3),
with an AUC = 0.934. The model was also reliable by a number of measures: the Hosmer-
Lemeshow goodness-of-fit test yielded a p = 0.72 indicating a good fit; the model correctly
classified 89% of the subjects in the study; and a post-hoc bootstrap stepwise regression
confirmed that the same variables would be selected. The sensitivity analysis demonstrated
only a slight decrement of the AUC (to 0.91) when the maximum eosinophil count was removed
from the model, and no change in the AUC (0.934) when mean eosinophil count was
substituted.
When we stratified the study population by age status (adult vs child), for adults the same key
variables as listed above were retained in the model, with the AUC improving to 0.971. For
children, the same model yielded a lower AUC of 0.914. A second predictive model for children
was developed which included 8 key variables: male gender, the presence of heartburn, atopic
disease, food allergy, asthma, linear furrows on endoscopy, the maximum eosinophil count,
and eosinophil degranulation. The AUC for this model was 0.957.
Discussion
Because the clinical features and histologic findings of EoE are non-specific and can overlap
with GERD, and because distinguishing these two entities is critical for appropriate patient
care, we performed a case-control study comparing patients with EoE to those with GERD.
The goal was to determine factors that could reliably differentiate the two groups of patients.
We found that individual clinical factors (such as age and gender, symptoms of dysphagia and
food impaction, the presence of atopic disease, and the season of diagnosis), endoscopic
findings (such as rings, strictures, linear furrows, and white plaques), and histopathologic
features (such as maximum eosinophil count, the presence of eosinophil degranulation or
microabscesses, and the mucosal or biopsy distribution of eosinophils) differed substantially
between the EoE and study groups. While previous studies28–36 have identified similar features
in series of EoE patients, our study represents the most thorough examination of these
characteristics in a rigorous comparison with an appropriate control group. Moreover, because
any one of these individual factors does not have the ability to separate EoE from GERD alone
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(indeed, in our study, the prevalence of erosive esophagitis was the same in each group), our
modeling strategy identified a set of 9 easily measured factors in this patient population that
distinguished EoE from GERD with a high degree of discrimination. Importantly, multiple
factors above and beyond the eosinophil count, which can be non-specific,14–16 are included.
Previous studies have attempted to isolate factors differentiating subjects with EoE from other
patient groups. Two similar studies, both prospective assessments of patients presenting for
EGD for evaluation of dysphagia, compared patients found to have EoE with the heterogeneous
group that did not have it.19, 20 Prasad and colleagues found that the 33 adult EoE patients
identified tended to be younger, present with food impaction, and have typical (rings, furrows,
strictures, white plaques) endoscopic features.19 Mackenzie and colleagues found that the EoE
patients (n = 31) also tended to be younger, and have more food allergies and asthma.20 Two
retrospective studies of pediatric populations are also pertinent. Franciosi and colleagues
compared a very large series of patients with EoE (n = 335) to clinic-based geographically
matched controls in the greater Philadelphia area, as well as to 2000 United States census data,
in an analysis primarily limited to demographic data.17 Aceves and colleagues reviewed their
pathology database and compared EoE patients (n = 102) to non-EoE controls with mild
esophageal eosinophilia who were presumed to have GERD (n = 102).18 They performed a
detailed histologic analysis and found the EoE patients had more basal zone hyperplasia, as
well as more eosinophil degranulation and microabscesses. Similar findings were reported in
adult patients by Parfitt and colleagues, in an analysis of 41 patients with EoE and 116 patients
who did not have EoE and were also presumed to have GERD.23
Several other smaller studies have directly compared histologic features of esophageal biopsies
in EoE and GERD patients. Steiner and colleagues reported prominent basal zone hyperplasia
in pediatric patients with EoE as compared with GERD, with the diagnosis of GERD confirmed
by pH monitoring.21 Additional investigators have recently applied immunohistochemical
techniques to stain for mast cell tryptase22, 24 and eosinophil-granule related markers such as
eosinophil peroxidase,22, 37 in an attempt to more readily distinguish EoE and GERD. Despite
these multiple reports, none had previously attempted to combine the pertinent clinical,
endoscopic, and histologic features in a model to predict the presence of EoE.
When interpreting the results of our study, there are several limitations to consider. First,
because this is a retrospective study, it is subject to potential misclassification bias and the
effect of missing data. Because we recognized these potential limitations during the design of
the study, we took specific steps to make sure cases and controls were defined carefully in an
a priori fashion. Though we identified multiple possible cases of EoE, we only included in this
study those which we considered to be definitive cases of EoE. In addition, we confirmed that
more than half of the patients in the EoE group had their esophageal biopsies performed on
acid suppression and that the remainder did not have a symptomatic improvement with acid
suppression. Because the symptomatic assessment was determined retrospectively from the
medical records, this could have introduced bias. However, we also went beyond the consensus
guideline diagnostic criteria1 to ensure all other potential causes of esophageal eosinophilia
were excluded. We extensively searched all available databases to minimize missing data, and
while there were variables with data missing, this was non-differentially distributed between
the cases and controls. None of the variables appearing in the final predictive model had more
than 10% of the data missing, with the exception of food allergy (28%).
It is also possible that our GERD control group is heterogenous. As can be seen from the range
of symptoms and endoscopic findings in this group, there were patients with dyspepsia, as well
as patients with both erosive and non-erosive disease included in this group. Additionally,
because patients of all ages were included in this study, it is important to remember that typical
symptoms of GERD in young children (reflux, vomiting/spitting up, abdominal pain, failure
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to thrive) are different than the more typical symptoms in adults. Nevertheless, all of the GERD
patients met the same a priori definition for study inclusion, and all had evidence of
inflammation on biopsy. The fact that the eosinophil count for the GERD group is higher than
generally reported in the literature38, 39 is directly attributable to our case finding strategy and
this disease definition. However, this is also the group of patients in whom it is most challenging
to distinguish from EoE patients in practice, making it the most informative to use as a control.
A final limitation is that because this is a single center experience, with a referral center for
esophageal diseases and pathologists specifically interested in gastrointestinal disorders, the
results may not be generalizable to other settings. However, our findings argue against this.
We found many of the characteristics previously reported to be associated with EoE present
in our case group, and have corroborated other recently reported findings such as the seasonal
variation in the diagnosis of EoE. Our observation that symptoms of EoE vary by age has been
reported.40 Our finding that the endoscopic findings also vary with age, with more
inflammatory findings early in the disease and more fibrotic findings coming at an older age,
is striking and suggests a potentially progressive course of the condition.
There are several other strengths of this paper. First, this is the largest case-control study of
EoE vs GERD reported in the literature, and the only one to specifically develop a predictive
model of EoE. We were able to extract data on multiple thoroughly characterized clinical and
endoscopic features, and all pathology slides were re-reviewed using a previously validated
protocol.25, 26 In the context of a rigorous case definition and a rich database, we identified a
set of relatively simple, and routinely collected, factors that, when taken together, reliability
predict EoE in this patient population. Of note, this model will need to be validated in other
populations of EoE patients before it can be routinely used in practice.
In conclusion, we have presented the results of a large case-control study comparing the
clinical, endoscopic, and histologic features of EoE and GERD. Nine factors were found to
reliably predict EoE and distinguish it from GERD, including: age, dysphagia; documented
food allergy; esophageal rings, linear furrows, and white plaques or exudates on EGD; the
absence of a hiatal hernia on EGD; the maximum eosinophil count; and the presence of
eosinophil degranulation on the biopsy specimen. By focusing on this group of factors, which
can be readily determined during a new patient evaluation, rather than on a simple eosinophil
count, EoE and GERD were reliably distinguished in our cohort. Our model, after validation,
may help improve the diagnosis of this condition, and facilitate earlier effective therapy for
subjects with EoE patients.
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A: New cases of eosinophilic esophagitis diagnosed by year of the study time frame. Black
bars indicate pediatric cases (age < 18) and grey bars indicate adult cases (age ≥ 18). B: Annual
incidence rate of EoE over the study time frame, after accounting for procedure volume. The
black bar indicates the rate (number of new diagnoses per year) per 1000 EGDs performed.
The light grey bar indicates the rate per 1000 esophageal biopsies performed. The dark grey
bar indicates the rate per 1000 esophageal biopsies during EGDs performed for an indication
of dysphagia.
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A: Symptoms in the eosinophilic esophagitis group as stratified by mean age. Non-specific-
type symptoms are seen in younger age groups while more “typical” symptoms are seen in the
older patients. B: Symptoms in the EoE group as stratified by adult (age ≥ 18 years) or child
(age < 18) status. The stars represent significant differences in the prevalence of symptom types
between the groups. C: Endoscopic findings in the EoE group as stratified by mean age. Either
a normal esophagus or more inflammatory-type findings are reported in younger age groups,
while more “classic” or fibrotic findings are seen in older patients. D: Endoscopic findings in
the EoE group as stratified by adult or status. The stars represent significant differences in the
prevalence of endoscopic findings between the groups.
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Receiver operator characteristic (ROC) curve for the final predictive model differentiating EoE
from GERD. Variables in the model include: age at biopsy/diagnosis; dysphagia as a symptom;
the presence of a documented food allergy; the presence of rings on EGD; the presence of
linear furrows on EGD, the presence of white plaques or exudates seen on EGD; the presence
of a hiatal hernia on EGD; the maximum eosinophil count; and the presence of eosinophil
degranulation on the biopsy specimen.
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Mean age at biopsy (± SD, range) 24.9 ± 18.3 (0.7–77) 32.5 ± 24.7 (0.5–87) 0.001
    Adults ≥ 18 years (n, %) 73 (48) 124 (55) 0.21
Male subjects (n, %) 116 (77) 130 (58) < 0.001
Race (n, %) 0.01
    White 122 (81) 185 (83)
    Black 21 (14) 26 (12)
    Hispanic 0 (0) 8 (4)
    Asian 1 (1) 0 (0)
    Native American 2 (1) 3 (1)
    Other 5 (3) 0 (0)
Symptoms (n, %)‡
    Dysphagia 109 (73) 57 (28) < 0.001
    Food impaction 41 (30) 6 (3) < 0.001
    Heartburn 57 (42) 122 (56) 0.009
    Chest pain 10 (8) 26 (13) 0.13
    Abdominal pain 35 (26) 108 (52) < 0.001
    Nausea 25 (19) 38 (19) 0.99
    Vomiting 36 (27) 68 (33) 0.23
    Crying 0 (0) 3 (1) 0.16
    Failure to thrive 17 (13) 18 (9) 0.24
Atopic disease (n, %)
    Allergic rhinitis/dermatitis 48 (37) 27 (14) < 0.001
    Food allergy 22 (26) 5 (3) < 0.001
    Asthma 39 (30) 25 (12) < 0.001
Season of diagnosis (n, %)# 0.02
    Winter (December-February) 27 (18) 69 (26)
    Spring (March-May) 31 (21) 67 (26)
    Summer (June-August) 55 (36) 60 (23)
    Fall (September-November) 38 (25) 67 (25)
Medications (n, %)**
    Proton-pump inhibitors 69 (50) 123 (59) 0.08
    H2 receptor antagonists 20 (15) 34 (17) 0.64
    Inhaled steroids 20 (15) 16 (8) 0.05
    Leukotriene antagonists 8 (6) 8 (4) 0.41
Lab values (mean ± SD, range)
    Peripheral eosinophils (109/L) 0.49 ± 0.40 (0–2.3) 0.25 ± 0.17 (0–0.8) < 0.001
    IgE level (kU/L) 270 ± 348 (14–1254) 174 ± 319 (7–1045) 0.46
    ESR (mm/hour) 9.0 ± 11.1 (0–47) 9.1 ± 9.0 (0–45) 0.96
    CRP (mg/dL) 1.3 ± 2.2 (0–6) 0.9 ± 1.8 (0–4) 0.63
pH probe (n, %) 0.001
    Normal 12 (86) 3 (25)
    Acid reflux (by criteria) 0 (0) 8 (67)
    Borderline result 2 (14) 1 (8)
Esophageal manometry (n, %) 0.28
    Normal 2 (50) 7 (78)
    Ineffective esophageal motility 0 (0) 1 (11)
    Non-specific 2 (50) 1 (11)
*
Missing data accounted for ≤ 12% of all observations with the following exceptions: chest pain (13%); nausea (13%); crying (13%); failure to thrive
(13%); the presence of allergic rhinitis or dermatitis (14%); food allergy (28%); asthma (13%); and peripheral eosinophil count (47%). In all cases, missing
data were non-differentially distributed between the EoE and GERD groups. For clinical variables not routinely obtained in practice, there were more
missing data: IgE level (92%); ESR (73%); CRP (95%); pH probe (94%); and esophageal manometry (96%).
†
P values calculated with t-test for continuous variables and with chi-square for categorical variables
‡
Patients may have had more than one symptom
#
For seasons of diagnosis, the listed p value is the overall comparison between the two groups. Within the EoE group, p for trend = 0.007, and within the
GERD group, p for trend = 0.87, both calculated with the chi-squre goodness of fit test.
**
Medications were recorded if they were being used at the time of endoscopy and biopsy. At total of 79 of the 151 patients with EoE were on either a
PPI or an H2-receptor antagonist at the time of endoscopy.





















EGD main indication (n, %) < 0.001
    Dysphagia 48 (32) 21 (9)
    Dysphagia and other 28 (19) 18 (8)
    Dysphagia and heartburn 11 (7) 13 (6)
    Heartburn/reflux 20 (13) 31 (14)
    Heartburn and other 6 (4) 28 (12)
    Food impaction alone 6 (4) 2 (1)
    Abdominal pain (any) 17 (11) 67 (30)
    Weight loss/failure to thrive 5 (3) 3 (1)
    Nausea and/or vomiting 5 (3) 13 (6)
    Chest pain 2 (1) 3 (1)
    Anemia/GI bleeding 0 (0) 17 (8)
    Peptic ulcer disease 0 (0) 1 (0)
    Prior upper GI neoplasm 0 (0) 2 (1)
    Odynophagia 2 (1) 2 (1)
    Feeding intolerance 1 (1) 0 (0)
EGD done for any dysphagia (n, %) 87 (58) 52 (23) < 0.001
EGD done for any heartburn (n, %) 37 (25) 72 (32) 0.12
EGD findings (n, %)†
    Normal 31 (21) 62 (27) 0.16
    Rings 51 (34) 7 (3) < 0.001
    Stricture 26 (18) 17 (8) 0.003
    Narrowed esophagus 16 (11) 1 (0) < 0.001
    Linear furrows 30 (20) 3 (1) < 0.001
     “Crêpe-paper” mucosa 4 (3) 0 (0) 0.01
    White plaques 15 (10) 7 (3) 0.005
    Erythema 26 (18) 25 (11) 0.07
    Erosions 8 (5) 10 (4) 0.67
    Decreased vascularity 7 (5) 6 (3) 0.28
    Esophagitis 52 (35) 94 (42) 0.21
    Ulcerations 2 (1) 7 (3) 0.28
    Hiatal hernia 10 (7) 59 (26) < 0.001
Other findings (n, %) 0.004
    Schatzki’s ring 9 (6) 9 (4)
    External compression 1 (1) 0 (0)
    Nodule 3 (2) 7 (3)
    Lichenification 1 (1) 1 (0)
    Irregular z-line 0 (0) 14 (6)
    Patulous LES 0 (0) 2 (1)
    Polyp 0 (0) 3 (1)
    Prior fundoplication 3 (2) 8 (4)
    Candidal esophagitis 0 (0) 3 (1)
    Web 3 (2) 1 (0)
    Tortuous esophagus 1 (1) 1 (0)
    Acute food impaction 3 (2) 1 (0)
    Pseudodiverticula 0 (0) 1 (0)
    Granularity and/or friability 4 (3) 7 (3)
     “Boggy” esophagus 7 (5) 2 (1)
    No other finding 116 (77) 157 (69)
Dilation performed (n, %) 31 (21) 12 (5) < 0.001
*
P values calculated with chi-square for categorical variables
†
Patients may have had more than one EGD finding





















Biopsy location (n, %) < 0.001
  Gastroesophageal junction 5 (3) 26 (12)
  Distal esophagus 13 (9) 38 (17)
  Mid esophagus 7 (5) 12 (5)
  Proximal esophagus 3 (2) 1 (0)
  Multiple levels 51 (34) 24 (11)
  Not specified 72 (48) 125 (55)
Max eosinophil density (eos/mm2)
  Mean (± SD, range) 505 ± 456 (63–2536) 140 ± 207 (0–1570) < 0.001
  Median (IQR) 374 (208–606) 72 (10–182) < 0.001
Max eosinophil count†
  Mean (± SD, range) 121 ± 110 (15–609) 34 ± 50 (0–377) < 0.001
  Median (IQR) 90 (50–145) 17 (2–44) < 0.001
Mean eosinophil density (of 5 hpfs)
  Mean (± SD, range) 317 ± 265 (6–1471) 69 ± 102 (0–660) < 0.001
  Median (IQR) 243 (143–412) 32 (5–86) < 0.001
Mean eosinophil count (of 5 hpfs)†
  Mean (± SD, range) 76 ± 64 (1–353) 16 ± 24 (0–158) < 0.001
  Median (IQR) 53 (34–99) 8 (1–21) < 0.001
Histologic findings (n, %)
  Degranulation present 106 (94) 115 (52) < 0.001
  Microabscess present 76 (67) 43 (19) < 0.001
  Eosinophil mucosal distribution 0.004
    Basal 5 (5) 25 (16)
    Superficial 4 (4) 12 (8)
    Diffuse 102 (92) 121 (77)
  Eosinophil biopsy distribution < 0.001
    Patchy 39 (35) 151 (79)
    Diffuse 74 (65) 41 (21)
  Basal layer present 110 (97) 219 (99) 0.40
  Spongiosis present 101 (89) 132 (59) < 0.001
  Subepithelial tissue present 91 (81) 173 (78) 0.58
  Lamina propria fibrosis present 1 (1) 3 (2) 0.69
  Biopsy consistent with EoE‡ 100 (92) 72 (36) < 0.001
*
P values calculated with t-test for continuous variables and with chi-square for categorical variables
†
Calculated for a hpf area = 0.24 mm2
‡
Determined by the pathologists on examination of the biopsy specimen alone in the absence of clinical information
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Table 4
Multivariate model predicting EoE*
Predictor Odds ratio 95% CI p value
Age at biopsy† 0.98 0.95 – 1.00 0.09
Dysphagia (symptom) 11.8 3.77 – 36.8 < 0.001
Food allergy (documented) 11.2 2.79 – 45.0 0.001
Rings seen on EGD 9.9 1.93 – 51.1 0.006
Linear furrows seen on EGD 6.4 0.62 – 65.5 0.12
White plaques seen on EGD 5.4 0.49 – 58.5 0.17
Hiatal hernia present on EGD 0.21 0.04 – 1.00 0.05
Maximum eosinophil count‡ 1.01 1.01 – 1.02 < 0.001
Degranulating eosinophils 4.81 1.52 – 15.2 0.008
*
Multivariate logistic regression with a backwards elimination strategy was used to develop model variables.
†
Odds ratio represents the odds of being a case for a 1 year increase in age at biopsy.
‡
Odds ratio represents the odds of being a case for a one cell increase in eosinophil count.
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